We are live on ! Find out more
CVS icon

CVS Health

1,815 hedge funds and large institutions have $58.2B invested in CVS Health in 2020 Q3 according to their latest regulatory filings, with 114 funds opening new positions, 828 increasing their positions, 709 reducing their positions, and 144 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more call options, than puts

Call options by funds: $1.81B | Put options by funds: $1.16B

17% more repeat investments, than reductions

Existing positions increased: 828 | Existing positions reduced: 709

1.84% less ownership

Funds ownership: 78.06%76.22% (-1.8%)

3% less funds holding

Funds holding: 1,8631,815 (-48)

12% less capital invested

Capital invested by funds: $66.1B → $58.2B (-$7.97B)

21% less first-time investments, than exits

New positions opened: 114 | Existing positions closed: 144

45% less funds holding in top 10

Funds holding in top 10: 8446 (-38)

Holders
1,815
Holders Change
-48
Holders Change %
-2.58%
% of All Funds
36.62%
Holding in Top 10
46
Holding in Top 10 Change
-38
Holding in Top 10 Change %
-45.24%
% of All Funds
0.93%
New
114
Increased
828
Reduced
709
Closed
144
Calls
$1.81B
Puts
$1.16B
Net Calls
+$646M
Net Calls Change
-$38.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Impax Asset Management Group
801
Impax Asset Management Group
United Kingdom
$2.1M +$76.5K +1,229 +4%
ECM
802
ExodusPoint Capital Management
New York
$2.1M +$718K +11,540 +47%
HI
803
Horizon Investments
North Carolina
$2.1M -$4.74M -76,151 -68%
CCM
804
Cadence Capital Management
Massachusetts
$2.09M -$591K -9,503 -21%
PCIA
805
Prime Capital Investment Advisors
Kansas
$2.09M -$648K -10,415 -23%
HSA
806
Hussman Strategic Advisors
Maryland
$2.08M -$943K -15,150 -30%
CFMC
807
Curbstone Financial Management Corp
New Hampshire
$2.08M +$56.6K +910 +3%
IC
808
IEQ Capital
California
$2.08M +$445K +7,156 +25%
SNT
809
Security National Trust
West Virginia
$2.07M +$24.1K +388 +1%
JWCA
810
J.W. Cole Advisors
Florida
$2.06M +$853K +13,703 +64%
CNC
811
Citizens & Northern Corp
Pennsylvania
$2.04M -$14.8K -238 -0.7%
WKWM
812
Walter & Keenan Wealth Management
Indiana
$2.03M +$38.1K +613 +2%
PI
813
PEAK6 Investments
Illinois
$2.03M +$2.17M +34,834 New
MC
814
MRJ Capital
New York
$2.02M
IBOK
815
Independence Bank of Kentucky
Kentucky
$2.02M +$305K +4,899 +17%
SIM
816
Sonora Investment Management
Arizona
$2.01M +$1.68K +27 +0.1%
KRSITF
817
Kentucky Retirement Systems Insurance Trust Fund
Kentucky
$2M +$134K +2,149 +7%
RC
818
RBF Capital
California
$2M -$311K -5,000 -13%
SIC
819
SFE Investment Counsel
California
$1.99M +$101K +1,617 +5%
TRCT
820
Tower Research Capital (TRC)
New York
$1.99M +$1.4M +22,541 +197%
ECM
821
Everence Capital Management
Indiana
$1.98M
MA
822
Mutual Advisors
Nebraska
$1.96M +$262K +4,211 +14%
AC
823
Addison Capital
Pennsylvania
$1.96M -$1.74K -28 -0.1%
PCM
824
Parsons Capital Management
Rhode Island
$1.95M +$57.2K +920 +3%
UR
825
USCA RIA
Texas
$1.95M -$822K -13,208 -28%

CVS Hedge Fund Activity: Q3 2020 in Review

1,815 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2020, worth a combined $58.2B — down 12% from $66.1B a quarter earlier.

Sellers outnumbered buyers: 144 funds closed out of CVS and 114 opened new positions — a net loss of 30 holders — while 709 trimmed existing stakes and 828 added.

The largest buyer was Capital World Investors, adding an estimated $408M. The largest seller was Capital International Investors, cutting an estimated $708M.

  • 1,815 institutional investors held CVS Health (CVS) as of Q3 2020, down from 1,863 in Q2 2020.
  • Funds reported $58.2B of CVS Health stock for Q3 2020, down 12% quarter-over-quarter.
  • 114 funds opened new CVS Health positions in Q3 2020 and 144 closed out, a net change of -30 holders.
  • The largest CVS Health buyer in Q3 2020 was Capital World Investors, an estimated $408M added.
  • The largest CVS Health seller in Q3 2020 was Capital International Investors, an estimated $708M sold.

Based on aggregated 13F filings for Q3 2020.